-
Angiokinase inhibitors in non-small-cell lung cancer
Wei-Chen Lu, Chia-Chi Lin, & James Chih-Hsin Yang
Review Article: Clinical Investigation
-
Angiokinase inhibitors in non-small-cell lung cancer
Wei-Chen Lu, Chia-Chi Lin, & James Chih-Hsin Yang
Review Article: Clinical Investigation
-
Angiokinase inhibitors in non-small-cell lung cancer
Wei-Chen Lu, Chia-Chi Lin, & James Chih-Hsin Yang
Review Article: Clinical Investigation
-
Angiokinase inhibitors in non-small-cell lung cancer
Wei-Chen Lu, Chia-Chi Lin, & James Chih-Hsin Yang
Review Article: Clinical Investigation
-
Angiokinase inhibitors in non-small-cell lung cancer
Wei-Chen Lu, Chia-Chi Lin, & James Chih-Hsin Yang
Review Article: Clinical Investigation
-
Angiokinase inhibitors in non-small-cell lung cancer
Wei-Chen Lu, Chia-Chi Lin, & James Chih-Hsin Yang
Review Article: Clinical Investigation
-
Angiokinase inhibitors in non-small-cell lung cancer
Wei-Chen Lu, Chia-Chi Lin, & James Chih-Hsin Yang
Review Article: Clinical Investigation
-
Angiokinase inhibitors in non-small-cell lung cancer
Wei-Chen Lu, Chia-Chi Lin, & James Chih-Hsin Yang
Review Article: Clinical Investigation
-
Solving clinical trial delays: innovative solutions
Kavita Singh, M Abdul Salam, Raji Devarajan & Dorairaj Prabhakaran
Clinical Trail Perspective: Clinical Investigation
-
Solving clinical trial delays: innovative solutions
Kavita Singh, M Abdul Salam, Raji Devarajan & Dorairaj Prabhakaran
Clinical Trail Perspective: Clinical Investigation
-
Solving clinical trial delays: innovative solutions
Kavita Singh, M Abdul Salam, Raji Devarajan & Dorairaj Prabhakaran
Clinical Trail Perspective: Clinical Investigation
-
Solving clinical trial delays: innovative solutions
Kavita Singh, M Abdul Salam, Raji Devarajan & Dorairaj Prabhakaran
Clinical Trail Perspective: Clinical Investigation
-
Solving clinical trial delays: innovative solutions
Kavita Singh, M Abdul Salam, Raji Devarajan & Dorairaj Prabhakaran
Clinical Trail Perspective: Clinical Investigation
-
Solving clinical trial delays: innovative solutions
Kavita Singh, M Abdul Salam, Raji Devarajan & Dorairaj Prabhakaran
Clinical Trail Perspective: Clinical Investigation
-
Solving clinical trial delays: innovative solutions
Kavita Singh, M Abdul Salam, Raji Devarajan & Dorairaj Prabhakaran
Clinical Trail Perspective: Clinical Investigation
-
Solving clinical trial delays: innovative solutions
Kavita Singh, M Abdul Salam, Raji Devarajan & Dorairaj Prabhakaran
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: interpretation
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: interpretation
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: interpretation
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: interpretation
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: interpretation
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: interpretation
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: interpretation
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: interpretation
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Statistical inference of adaptive randomized clinical trials for personalized medicine
Feifang Hu, Yanqing Hu, Wei Ma, Lixin Zhang & Hongjian Zhu
Clinical Trail Methodology: Clinical Investigation
-
Statistical inference of adaptive randomized clinical trials for personalized medicine
Feifang Hu, Yanqing Hu, Wei Ma, Lixin Zhang & Hongjian Zhu
Clinical Trail Methodology: Clinical Investigation
-
Statistical inference of adaptive randomized clinical trials for personalized medicine
Feifang Hu, Yanqing Hu, Wei Ma, Lixin Zhang & Hongjian Zhu
Clinical Trail Methodology: Clinical Investigation
-
Statistical inference of adaptive randomized clinical trials for personalized medicine
Feifang Hu, Yanqing Hu, Wei Ma, Lixin Zhang & Hongjian Zhu
Clinical Trail Methodology: Clinical Investigation
-
Statistical inference of adaptive randomized clinical trials for personalized medicine
Feifang Hu, Yanqing Hu, Wei Ma, Lixin Zhang & Hongjian Zhu
Clinical Trail Methodology: Clinical Investigation
-
Statistical inference of adaptive randomized clinical trials for personalized medicine
Feifang Hu, Yanqing Hu, Wei Ma, Lixin Zhang & Hongjian Zhu
Clinical Trail Methodology: Clinical Investigation
-
Statistical inference of adaptive randomized clinical trials for personalized medicine
Feifang Hu, Yanqing Hu, Wei Ma, Lixin Zhang & Hongjian Zhu
Clinical Trail Methodology: Clinical Investigation
-
Statistical inference of adaptive randomized clinical trials for personalized medicine
Feifang Hu, Yanqing Hu, Wei Ma, Lixin Zhang & Hongjian Zhu
Clinical Trail Methodology: Clinical Investigation
-
Pediatric trials of antihypertensive agents: impact of trial design and unique pediatric factors on efficacy end points
Kevin D Hill, Patricia Y Chu, Jennifer S Li & Christoph P Hornik
Clinical Trail Methodology: Clinical Investigation
-
Pediatric trials of antihypertensive agents: impact of trial design and unique pediatric factors on efficacy end points
Kevin D Hill, Patricia Y Chu, Jennifer S Li & Christoph P Hornik
Clinical Trail Methodology: Clinical Investigation
-
Pediatric trials of antihypertensive agents: impact of trial design and unique pediatric factors on efficacy end points
Kevin D Hill, Patricia Y Chu, Jennifer S Li & Christoph P Hornik
Clinical Trail Methodology: Clinical Investigation
-
Pediatric trials of antihypertensive agents: impact of trial design and unique pediatric factors on efficacy end points
Kevin D Hill, Patricia Y Chu, Jennifer S Li & Christoph P Hornik
Clinical Trail Methodology: Clinical Investigation
-
Pediatric trials of antihypertensive agents: impact of trial design and unique pediatric factors on efficacy end points
Kevin D Hill, Patricia Y Chu, Jennifer S Li & Christoph P Hornik
Clinical Trail Methodology: Clinical Investigation
-
Pediatric trials of antihypertensive agents: impact of trial design and unique pediatric factors on efficacy end points
Kevin D Hill, Patricia Y Chu, Jennifer S Li & Christoph P Hornik
Clinical Trail Methodology: Clinical Investigation
-
Pediatric trials of antihypertensive agents: impact of trial design and unique pediatric factors on efficacy end points
Kevin D Hill, Patricia Y Chu, Jennifer S Li & Christoph P Hornik
Clinical Trail Methodology: Clinical Investigation
-
Pediatric trials of antihypertensive agents: impact of trial design and unique pediatric factors on efficacy end points
Kevin D Hill, Patricia Y Chu, Jennifer S Li & Christoph P Hornik
Clinical Trail Methodology: Clinical Investigation